TARGETING MHCII UBIQUITINATION TO INDUCE IMMUNE REGULATION IN VASCULARIZED COMPOSITE TISSUE TRANSPLANTATION

$992,302FY2025Defense Health AgencyDOD

The General Hospital Corporation

Investigators